Cargando…
Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study
PURPOSE: To assess the efficacy, safety, and pharmacokinetics of new topical ocular anti-TNFα antibody fragment licaminlimab in the relief of persistent ocular discomfort in severe dry eye disease (DED). PATIENTS AND METHODS: Patients with ≥6-month history of DED, regular use of artificial tears, an...
Autores principales: | Shettle, Lee, McLaurin, Eugene, Martel, Joseph, Seaman, John W, Weissgerber, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271287/ https://www.ncbi.nlm.nih.gov/pubmed/35821785 http://dx.doi.org/10.2147/OPTH.S366836 |
Ejemplares similares
-
Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study
por: Pasquali, Theodore A., et al.
Publicado: (2022) -
A novel TRPM8 agonist relieves dry eye discomfort
por: Yang, Jee Myung, et al.
Publicado: (2017) -
Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration
por: Ankamah, Emmanuel, et al.
Publicado: (2021) -
Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
por: McLaurin, Eugene B., et al.
Publicado: (2014) -
Low‐dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials
por: Ackerman, Stacey L, et al.
Publicado: (2018)